Cel Sci Corporation (CVM)

[lightrock]

42% way over at the right comes from Phase 2 study

42% of those injected had any kind of response at all

The rest had no kind of response to injection at all

( Since that is the only such information published it is the only information I can use in my model )

But it makes the point, "it appears as only 42% of the test group are responsible to make a showing equivalent to 10% OAS of the entire test group vs. SOC"

Until new information is available, that's the best I can do.

So you see, the bar is really high. This "gold standard study".

Choosing what is the SOC is extremely important. This is what I settled on.

"
* This area uses the Table 5, 49.8% 5 year OAS from
and article in The Oncologist
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228039/
"

That number, AS I - referred to THIS article, is what Cel-Sci said is the right one from that article ( if I were to use that article )